Home » Topics » Regulatory » Patents

Patents
RSS

Celgene reports dual TNF/PDE inhibitors

April 17, 1997

Pfizer describes substance P antagonists

April 17, 1997

Excitatory amino acid antagonists from Novartis

April 17, 1997

Retroviral protease inhibitors disclosed by DuPont Merck

April 17, 1997

Pharmacia & Upjohn describes agents for 5-HT1A receptor-mediated disorders

April 17, 1997

SKB describes 5-HT2C/5-HT2B antagonists

April 17, 1997

Novel bisphosphonates revealed by Yissum

April 17, 1997

Esters of estrogenic compounds from Lilly

April 16, 1997

Meiji Seika discloses new cardiotonic agents

April 16, 1997

5-HT2 antagonists/5-HT reuptake inhibitors described by Yamanouchi

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...